Campbell & CO Investment Adviser LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$345,000
+70.8%
14,800
+39.6%
0.12%
+78.8%
Q3 2021$202,000
-7.8%
10,600
-11.4%
0.07%
-50.7%
Q1 2021$219,000
-30.3%
11,961
-23.5%
0.13%
-30.2%
Q4 2020$314,000
+4.0%
15,627
-3.1%
0.19%
-14.7%
Q3 2020$302,000
-29.8%
16,127
-15.7%
0.22%
-58.6%
Q2 2020$430,000
-1.8%
19,127
-18.1%
0.54%
+47.8%
Q1 2018$438,00023,3410.37%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders